UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (10) 10
life sciences & biomedicine (10) 10
science & technology (10) 10
male (9) 9
female (8) 8
middle aged (8) 8
aged (7) 7
care and treatment (6) 6
lung cancer (6) 6
oncology (6) 6
adult (5) 5
cancer (5) 5
lung neoplasms - drug therapy (5) 5
carcinoma, non-small-cell lung - drug therapy (4) 4
chemotherapy (4) 4
lung cancer, non-small cell (4) 4
metastasis (4) 4
mutation (4) 4
toxicity (4) 4
aged, 80 and over (3) 3
analysis (3) 3
brain neoplasms - secondary (3) 3
carcinoma, non-small-cell lung - genetics (3) 3
hematology, oncology and palliative medicine (3) 3
lung neoplasms - genetics (3) 3
lung neoplasms - pathology (3) 3
medical research (3) 3
pharmaceuticals (3) 3
survival (3) 3
abridged index medicus (2) 2
antineoplastic agents - adverse effects (2) 2
antineoplastic agents - therapeutic use (2) 2
cancer therapies (2) 2
carbazoles - therapeutic use (2) 2
carcinoma, non-small-cell lung - metabolism (2) 2
cell survival (2) 2
clinical trials (2) 2
college teachers (2) 2
death (2) 2
exons (2) 2
general & internal medicine (2) 2
internal medicine (2) 2
lung neoplasms - metabolism (2) 2
magnetic resonance imaging (2) 2
medical colleges (2) 2
medical imaging (2) 2
medicine, experimental (2) 2
medicine, general & internal (2) 2
motivation (2) 2
neoplasm grading (2) 2
neoplasm staging (2) 2
oncology, experimental (2) 2
original (2) 2
original article (2) 2
piperidines - therapeutic use (2) 2
platinum (2) 2
product development (2) 2
protein kinase inhibitors - therapeutic use (2) 2
receptor protein-tyrosine kinases - antagonists & inhibitors (2) 2
receptor protein-tyrosine kinases - metabolism (2) 2
receptor, epidermal growth factor - genetics (2) 2
recruitment (2) 2
research (2) 2
respiratory agents (2) 2
risk factors (2) 2
10-year follow-up (1) 1
5-ht (1) 1
5-ht release (1) 1
adenocarcinoma - drug therapy (1) 1
adenocarcinoma - genetics (1) 1
adenocarcinoma - metabolism (1) 1
adenocarcinoma - pathology (1) 1
adenocarcinoma - radiotherapy (1) 1
adenocarcinoma - secondary (1) 1
alleles (1) 1
amino acid substitution (1) 1
anorexia (1) 1
anti-inflammatory agents, non-steroidal - administration & dosage (1) 1
antibodies, monoclonal, humanized - therapeutic use (1) 1
anticancer drug-induced emesis (1) 1
antineoplastic agents - administration & dosage (1) 1
antineoplastic agents - blood (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
antitumor activity (1) 1
apoptosis (1) 1
asian continental ancestry group (1) 1
audio frequencies (1) 1
b7-h1 antigen - metabolism (1) 1
bayesian analysis (1) 1
bevacizumab (1) 1
bevacizumab - therapeutic use (1) 1
biomarkers - metabolism (1) 1
biopsy (1) 1
brain - diagnostic imaging (1) 1
brain - pathology (1) 1
brain - surgery (1) 1
brain metastasis (1) 1
brain neoplasms - diagnostic imaging (1) 1
brain neoplasms - pathology (1) 1
brain neoplasms - prevention & control (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The lancet oncology, ISSN 1470-2045, 2017, Volume 18, Issue 5, pp. 663 - 671
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2017, Volume 390, Issue 10089, pp. 29 - 39
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Single-Blind Method | Lung Neoplasms - drug therapy | Pyrazoles - therapeutic use | Humans | Middle Aged | Lung Neoplasms - pathology | Male | Antineoplastic Agents - therapeutic use | Protein Kinase Inhibitors - adverse effects | Piperidines - blood | Brain Neoplasms - secondary | Pyridines - adverse effects | Carcinoma, Non-Small-Cell Lung - secondary | Neoplasm Grading | Antineoplastic Agents - adverse effects | Pyrazoles - blood | Aged, 80 and over | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Adult | Female | Carbazoles - blood | Pyrazoles - adverse effects | Pyridines - therapeutic use | Carcinoma, Non-Small-Cell Lung - pathology | Carbazoles - adverse effects | Lung Neoplasms - enzymology | Kaplan-Meier Estimate | Receptor Protein-Tyrosine Kinases - metabolism | Protein Kinase Inhibitors - blood | Pyridines - blood | Piperidines - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Piperidines - adverse effects | Antineoplastic Agents - blood | Aged | Carbazoles - therapeutic use | Carcinoma, Non-Small-Cell Lung - drug therapy | Carcinoma, Non-Small-Cell Lung - enzymology | Medical colleges | Respiratory agents | Care and treatment | Lymphomas | Lung cancer, Non-small cell | Product development | Pharmaceutical industry | Analysis | Toxicity | Funding | Lung cancer | Central nervous system | Metastasis | Kinases | Evidence-based medicine | Recruitment | Motivation | Audio frequencies | Safety | Toxic diseases | Drug dosages | Protein-tyrosine kinase | Effectiveness | Data processing | Group dynamics | Patients | Survival | Lymphoma | Chemotherapy | Inhibitors | Interactive systems | Death | Mutation | Cancer | Pharmaceuticals | Index Medicus | Abridged Index Medicus
Journal Article
The lancet oncology, ISSN 1470-2045, 2010, Volume 11, Issue 2, pp. 121 - 128
Journal Article
The lancet oncology, ISSN 1470-2045, 2013, Volume 14, Issue 7, pp. 590 - 598
Journal Article
Journal Article